If Clarity results on many more patients and data proves current assertions it is much more accurate and given its radiopharmaceutical production system would be much cheaper and easier , I do not see how the two companies could both continue concurrently. If Clarity turns out to be this disruptor I am not sure if Telix could convert its considerable investment to date in its production of its radiopharmaceuticals to Clarity tech, cost effectively , to allow for a merger. Would be GREAT if it could happen though for Australia biotech industry and our global profile in Biotech . Any such merger would need financing and there is always big pharma with their massive budgets that could swoop in to pruchase it . Would need a technical expert in this arena to help inform us on this .I suspect there are many of us heavily invested in Telix hedging our bets by investing in Clarity as well now and depending on results through this year this trend would continue.
CU6 Price at posting:
$3.92 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)